Literature DB >> 31673458

Prescribing Patterns of Continuous Infusions in Nonobese versus Obese Children Admitted to the Pediatric Intensive Care Unit.

Peter N Johnson1, Katy Stephens2, Philip Barker2, Erica Bergeron2, Sin Yin Lim1, Tracy M Hagemann2, Teresa V Lewis1, Stephen Neely2, Jamie L Miller1.   

Abstract

This retrospective study compared the continuous infusions prescribed for obese and nonobese children. Ninety-five (13.2%) received an infusion. A greater percentage of obese ( n  = 42/168) versus nonobese (53/552) children received infusions, p  < 0.01. No difference was noted in the median number of infusions between the obese and nonobese groups, 2 versus 2, p  = 0.975. The top 20 prescribed infusions included ten (50%) for sedation/analgesia or neuromuscular blockade and six (30%) for hemodynamic support. A literature search was performed for these 20 agents to determine pharmacokinetics, pharmacodynamics, and dosing in obese children and revealed six studies evaluating fentanyl ( n  = 2), midazolam ( n  = 1), and propofol ( n  = 3). © Thieme Medical Publishers.

Entities:  

Keywords:  children; obesity; pharmacokinetics

Year:  2019        PMID: 31673458      PMCID: PMC6821521          DOI: 10.1055/s-0039-1692669

Source DB:  PubMed          Journal:  J Pediatr Intensive Care        ISSN: 2146-4626


  42 in total

1.  Altered gentamicin serum concentrations in obese pediatric patients.

Authors:  Jamie J Choi; Brady S Moffett; Erin J McDade; Debra L Palazzi
Journal:  Pediatr Infect Dis J       Date:  2011-04       Impact factor: 2.129

2.  Pharmacokinetics and drug dosing in obese children.

Authors:  Jennifer G Kendrick; Roxane R Carr; Mary H H Ensom
Journal:  J Pediatr Pharmacol Ther       Date:  2010-04

3.  An aid to drug dosing safety in obese children: development of a new nomogram and comparison with existing methods for estimation of ideal body weight and lean body mass.

Authors:  L C Callaghan; J D Walker
Journal:  Anaesthesia       Date:  2014-10-07       Impact factor: 6.955

4.  Pharmacokinetic and pharmacodynamics of intravenous dexmedetomidine in morbidly obese patients undergoing laparoscopic surgery.

Authors:  Bo Xu; Dongxu Zhou; Li Ren; Steven Shulman; Xingan Zhang; Ming Xiong
Journal:  J Anesth       Date:  2017-08-21       Impact factor: 2.078

5.  Vasopressin deficiency contributes to the vasodilation of septic shock.

Authors:  D W Landry; H R Levin; E M Gallant; R C Ashton; S Seo; D D'Alessandro; M C Oz; J A Oliver
Journal:  Circulation       Date:  1997-03-04       Impact factor: 29.690

6.  Increased enoxaparin dosing is required for obese children.

Authors:  Teresa V Lewis; Peter N Johnson; Ashley M Nebbia; Marny Dunlap
Journal:  Pediatrics       Date:  2011-02-14       Impact factor: 7.124

7.  Pharmacokinetic mass of fentanyl for postoperative analgesia in lean and obese patients.

Authors:  K Shibutani; M A Inchiosa; K Sawada; M Bairamian
Journal:  Br J Anaesth       Date:  2005-07-15       Impact factor: 9.166

8.  Propofol clearance in morbidly obese children and adolescents: influence of age and body size.

Authors:  Jeroen Diepstraten; Vidya Chidambaran; Senthilkumar Sadhasivam; Hope R Esslinger; Shareen L Cox; Thomas H Inge; Catherijne A J Knibbe; Alexander A Vinks
Journal:  Clin Pharmacokinet       Date:  2012-08-01       Impact factor: 6.447

9.  Dexmedetomidine pharmacokinetics in the obese.

Authors:  Luis I Cortínez; Brian J Anderson; Nick H G Holford; Valentina Puga; Natalia de la Fuente; Hernán Auad; Sandra Solari; Fidel A Allende; Mauricio Ibacache
Journal:  Eur J Clin Pharmacol       Date:  2015-09-26       Impact factor: 2.953

Review 10.  Antimicrobial dosing considerations in obese adult patients.

Authors:  Manjunath P Pai; David T Bearden
Journal:  Pharmacotherapy       Date:  2007-08       Impact factor: 4.705

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.